Biochemical Assessment of Coenzyme Q ₁₀ Deficiency

Abstract

Coenzyme Q ₁₀ (CoQ ₁₀) deficiency syndrome includes clinically heterogeneous mitochondrial diseases that show a variety of severe and debilitating symptoms. A multiprotein complex encoded by nuclear genes carries out CoQ ₁₀ biosynthesis. Mutations in any of these genes are responsible for the primary CoQ ₁₀ deficiency, but there are also different conditions that induce secondary CoQ ₁₀ deficiency including mitochondrial DNA (mtDNA) depletion and mutations in genes involved in the fatty acid β-oxidation pathway. The diagnosis of CoQ ₁₀ deficiencies is determined by the decrease of its content in skeletal muscle and/or dermal skin fibroblasts. Dietary CoQ ₁₀ supplementation is the only available treatment for these deficiencies that require a rapid and distinct diagnosis. Here we review methods for determining CoQ ₁₀ content by HPLC separation and identification using alternative approaches including electrochemical detection and mass spectrometry. Also, we review procedures to determine the CoQ ₁₀ biosynthesis rate using labeled precursors.